232 related articles for article (PubMed ID: 24591762)
1. Brachyury: a diagnostic marker for the differential diagnosis of chordoma and hemangioblastoma versus neoplastic histological mimickers.
Barresi V; Ieni A; Branca G; Tuccari G
Dis Markers; 2014; 2014():514753. PubMed ID: 24591762
[TBL] [Abstract][Full Text] [Related]
2. Specificity of brachyury in the distinction of chordoma from clear cell renal cell carcinoma and germ cell tumors: a study of 305 cases.
Sangoi AR; Karamchandani J; Lane B; Higgins JP; Rouse RV; Brooks JD; McKenney JK
Mod Pathol; 2011 Mar; 24(3):425-9. PubMed ID: 21102418
[TBL] [Abstract][Full Text] [Related]
3. Revisiting chordoma with brachyury, a "new age" marker: analysis of a validation study on 51 cases.
Jambhekar NA; Rekhi B; Thorat K; Dikshit R; Agrawal M; Puri A
Arch Pathol Lab Med; 2010 Aug; 134(8):1181-7. PubMed ID: 20670140
[TBL] [Abstract][Full Text] [Related]
4. Tissue microarray immunohistochemical detection of brachyury is not a prognostic indicator in chordoma.
Zhang L; Guo S; Schwab JH; Nielsen GP; Choy E; Ye S; Zhang Z; Mankin H; Hornicek FJ; Duan Z
PLoS One; 2013; 8(9):e75851. PubMed ID: 24086644
[TBL] [Abstract][Full Text] [Related]
5. Brachyury expression in intracranial SMARCB1-deficient tumors: important points for distinguishing poorly differentiated chordoma from atypical teratoid/rhabdoid tumor.
Kohashi K; Yamamoto H; Yamada Y; Kinoshita I; Oda Y
Hum Pathol; 2021 Jun; 112():1-8. PubMed ID: 33741347
[TBL] [Abstract][Full Text] [Related]
6. Diagnosing an extra-axial chordoma of the proximal tibia with the help of brachyury, a molecule required for notochordal differentiation.
O'donnell P; Tirabosco R; Vujovic S; Bartlett W; Briggs TW; Henderson S; Boshoff C; Flanagan AM
Skeletal Radiol; 2007 Jan; 36(1):59-65. PubMed ID: 16810540
[TBL] [Abstract][Full Text] [Related]
7. Patterns of brachyury expression in chordomas.
Dridi M; Boutonnat J; Dumollard JM; Peoc'h M; Karpathiou G
Ann Diagn Pathol; 2021 Aug; 53():151760. PubMed ID: 33989961
[TBL] [Abstract][Full Text] [Related]
8. Classic chordoma coexisting with benign notochordal cell rest demonstrating different immunohistological expression patterns of brachyury and galectin-3.
Shen J; Li CD; Yang HL; Lu J; Zou TM; Wang DL; Deng M
J Clin Neurosci; 2011 Jan; 18(1):96-9. PubMed ID: 20855213
[TBL] [Abstract][Full Text] [Related]
9. Brachyury gene copy number gain and activation of the PI3K/Akt pathway: association with upregulation of oncogenic Brachyury expression in skull base chordoma.
Otani R; Mukasa A; Shin M; Omata M; Takayanagi S; Tanaka S; Ueki K; Saito N
J Neurosurg; 2018 May; 128(5):1428-1437. PubMed ID: 28753115
[TBL] [Abstract][Full Text] [Related]
10. Expression of brachyury in hemangioblastoma: potential use in differential diagnosis.
Barresi V; Vitarelli E; Branca G; Antonelli M; Giangaspero F; Barresi G
Am J Surg Pathol; 2012 Jul; 36(7):1052-7. PubMed ID: 22446946
[TBL] [Abstract][Full Text] [Related]
11. Generation of chordoma cell line JHC7 and the identification of Brachyury as a novel molecular target.
Hsu W; Mohyeldin A; Shah SR; ap Rhys CM; Johnson LF; Sedora-Roman NI; Kosztowski TA; Awad OA; McCarthy EF; Loeb DM; Wolinsky JP; Gokaslan ZL; Quiñones-Hinojosa A
J Neurosurg; 2011 Oct; 115(4):760-9. PubMed ID: 21699479
[TBL] [Abstract][Full Text] [Related]
12. Novel immunohistochemical markers in the diagnosis of nonglial tumors of nervous system.
Takei H; Powell SZ
Adv Anat Pathol; 2010 Mar; 17(2):150-3. PubMed ID: 20179436
[TBL] [Abstract][Full Text] [Related]
13. Notochordal Tumors: An Update on Molecular Pathology with Therapeutic Implications.
Yamaguchi T; Imada H; Iida S; Szuhai K
Surg Pathol Clin; 2017 Sep; 10(3):637-656. PubMed ID: 28797506
[TBL] [Abstract][Full Text] [Related]
14. From notochord formation to hereditary chordoma: the many roles of Brachyury.
Nibu Y; José-Edwards DS; Di Gregorio A
Biomed Res Int; 2013; 2013():826435. PubMed ID: 23662285
[TBL] [Abstract][Full Text] [Related]
15. Brachyury: A sensitive marker, but not a prognostic factor, for skull base chordomas.
Wang K; Tian K; Wang L; Wu Z; Ren C; Hao S; Feng J; Li J; Wan H; Jia G; Zhang L; Zhang J
Mol Med Rep; 2015 Sep; 12(3):4298-4304. PubMed ID: 26099340
[TBL] [Abstract][Full Text] [Related]
16. Poorly differentiated extra-axial extraskeletal chordoma diagnosed by methylation profiling: case report and analysis of brachyury expression in SWI/SNF-deficient tumors.
Klubíčková N; Michal M; Kinkor Z; Soukup J; Ryška A; Brtková J; Lutonský M; Hájková V; Ptáková N; Michal M; Farkas M; Švajdler M
Virchows Arch; 2024 Apr; 484(4):621-627. PubMed ID: 37594643
[TBL] [Abstract][Full Text] [Related]
17. Histological study of chordoma origin from fetal notochordal cell rests.
Shen J; Shi Q; Lu J; Wang DL; Zou TM; Yang HL; Zhu GQ
Spine (Phila Pa 1976); 2013 Dec; 38(25):2165-70. PubMed ID: 24296480
[TBL] [Abstract][Full Text] [Related]
18. Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue.
Tirabosco R; Mangham DC; Rosenberg AE; Vujovic S; Bousdras K; Pizzolitto S; De Maglio G; den Bakker MA; Di Francesco L; Kalil RK; Athanasou NA; O'Donnell P; McCarthy EF; Flanagan AM
Am J Surg Pathol; 2008 Apr; 32(4):572-80. PubMed ID: 18301055
[TBL] [Abstract][Full Text] [Related]
19. Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis.
Oakley GJ; Fuhrer K; Seethala RR
Mod Pathol; 2008 Dec; 21(12):1461-9. PubMed ID: 18820665
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of chordoma xenografts generated from a novel primary chordoma cell source and two chordoma cell lines.
Karikari IO; Gilchrist CL; Jing L; Alcorta DA; Chen J; Richardson WJ; Gabr MA; Bell RD; Kelley MJ; Bagley CA; Setton LA
J Neurosurg Spine; 2014 Sep; 21(3):386-93. PubMed ID: 24905390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]